Literature DB >> 9150723

Alternative splicing of hMSH2 in normal human tissues.

Y Mori1, H Shiwaku, S Fukushige, S Wakatsuki, M Sato, T Nukiwa, A Horii.   

Abstract

hMSH2 is a homolog of bacterial mutS and yeast Msh2, a member of the group of mismatch repair genes whose products bind to mismatched regions of double-stranded DNA. We analyzed expression of hMSH2 in normal human organs by the polymerase chain reaction coupled with reverse transcription and found two novel types of alternatively spliced mRNAs that were expressed in normal human organs. One lacked exon 13, and the other lacked a portion from the second nucleotide of codon 633 to the second nucleotide of codon 719. In the latter transcript, intro 12 started with TA and ended with TT (TA-TT intron) which did not meet the GT-AG rule. Both types of transcript resulted in frameshifts which generated truncated hMSH2 proteins lacking the main part of the highly conserved region. The biological significance of the alternative splicing remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150723     DOI: 10.1007/s004390050411

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

Review 1.  AT-AC pre-mRNA splicing mechanisms and conservation of minor introns in voltage-gated ion channel genes.

Authors:  Q Wu; A R Krainer
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis.

Authors:  Masaharu Ishida; Makoto Sunamura; Toru Furukawa; Masanori Akada; Hiroko Fujimura; Emiko Shibuya; Shinichi Egawa; Michiaki Unno; Akira Horii
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

3.  Full-length transcript amplification and sequencing as universal method to test mRNA integrity and biallelic expression in mismatch repair genes.

Authors:  Monika Morak; Kerstin Schaefer; Verena Steinke-Lange; Udo Koehler; Susanne Keinath; Trisari Massdorf; Brigitte Mauracher; Nils Rahner; Jessica Bailey; Christiane Kling; Tanja Haeusser; Andreas Laner; Elke Holinski-Feder
Journal:  Eur J Hum Genet       Date:  2019-07-22       Impact factor: 4.246

4.  Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma.

Authors:  Takenori Ogawa; Kazumi Ogawa; Kiyoto Shiga; Toru Furukawa; Hiroki Nagase; Sho Hashimoto; Toshimitsu Kobayashi; Akira Horii
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-05       Impact factor: 2.503

5.  Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.

Authors:  Shanhai Xu; Toru Furukawa; Naomi Kanai; Makoto Sunamura; Akira Horii
Journal:  J Hum Genet       Date:  2005-04-12       Impact factor: 3.172

6.  A cDNA microarray analysis identifies 52 genes associated with cis-diamminedichloroplatinum susceptibility in head and neck squamous cell carcinoma cell lines.

Authors:  Takenori Ogawa; Toru Furukawa; Kiyoto Shiga; Sho Hashimoto; Kazumi Ogawa; Toshimitsu Kobayashi; Akira Horii
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

7.  Extensive molecular screening for hereditary non-polyposis colorectal cancer.

Authors:  B Dieumegard; S Grandjouan; J C Sabourin; M L Le Bihan; I Lefrère; J P Pignon; P Rougier; P Lasser; J Bénard; D Couturier; B Bressac-de Paillerets
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

8.  Chromosome band 16q24 is frequently deleted in human gastric cancer.

Authors:  Y Mori; M Matsunaga; T Abe; S Fukushige; K Miura; M Sunamura; K Shiiba; M Sato; T Nukiwa; A Horii
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

9.  Expression of the DMBT1 gene is frequently suppressed in human lung cancer.

Authors:  H Takeshita; M Sato; H O Shiwaku; S Semba; A Sakurada; M Hoshi; Y Hayashi; Y Tagawa; H Ayabe; A Horii
Journal:  Jpn J Cancer Res       Date:  1999-09

10.  Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.

Authors:  Yasuhiko Mizuguchi; Yuriko Saiki; Akira Horii; Shinichi Fukushige
Journal:  Cancer Med       Date:  2016-07-25       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.